ÂÜÀòÂÒÂ×

Shannon Delgado is a highly accomplished Senior Area Business Specialist currently at Xeris Pharmaceuticals, Inc. since October 2021, following the merger with Strongbridge Biopharma. Shannon has a proven track record in the orphan drug market, notably launching Recorlev for Cushing's Syndrome and achieving significant recognition, including President's Club Winner and national rankings for new patient starts. Prior experiences include successful tenures at Strongbridge Biopharma and Grifols, where Shannon earned multiple awards for sales excellence and patient engagement, such as the Area Business Specialist of the Year and induction into the Elite Platinum Club. With a Bachelor of Science in Health Services from the University of Florida, Shannon has consistently demonstrated exceptional sales performance and strategic understanding across various therapeutic areas.